Kevin L. Roberg

Kevin L. Roberg discloses dealings in 3 companies, chiefly Omnicell, Inc., Thomas & Betts Corp and Compellent Technologies Inc. We count 26 filings; the first trade dates from 15 August 2006 and the latest from 16 May 2012.

Both buying and selling appear: 2 purchases worth €104k, against 4 sales worth €1.6M. Netting one side against the other leaves €1.5M of net selling. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 8 share grants and 10 option exercises.

Most recently, on 17 May 2012, the filings show a transaction worth €565k in Thomas & Betts Corp. The clock since the last published purchase (18 May 2010) now reads 6,002 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.